Robin L Jones Selected Research

Robin L Jones Research Topics

Disease

110	Sarcoma (Soft Tissue Sarcoma) 05/2024 - 07/2007
92	Neoplasms (Cancer) 03/2024 - 07/2004
24	Liposarcoma 01/2023 - 12/2005
22	Leiomyosarcoma 10/2023 - 12/2011
21	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2024 - 05/2013
21	Breast Neoplasms (Breast Cancer) 10/2019 - 07/2004
16	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2007
14	Disease Progression 01/2024 - 03/2016
13	Synovial Sarcoma (Synovioma) 01/2022 - 05/2011
11	Cardiotoxicity 10/2022 - 07/2004
9	Hemangiosarcoma (Angiosarcoma) 05/2023 - 10/2012
9	Testicular Neoplasms (Testicular Cancer) 01/2022 - 01/2011
8	Myxoid Liposarcoma 11/2022 - 12/2005
7	Fatigue 11/2022 - 01/2018
6	Ewing Sarcoma (Sarcoma, Ewing) 01/2023 - 05/2010
5	Osteosarcoma (Osteogenic Sarcoma) 05/2023 - 05/2015
5	Clear Cell Sarcoma 01/2023 - 09/2011
5	Nausea 01/2022 - 07/2016
5	Anemia 01/2022 - 01/2017
5	Aggressive Fibromatosis (Desmoid) 12/2020 - 11/2009
4	Carcinogenesis 01/2020 - 01/2007
3	Diarrhea 01/2022 - 10/2020
3	Vomiting 01/2022 - 07/2016
3	Carcinoma (Carcinomatosis) 12/2019 - 09/2007
3	Neutropenia 01/2018 - 07/2016
3	Febrile Neutropenia 01/2017 - 07/2016
2	Epithelioid Hemangioendothelioma 01/2024 - 01/2021
2	Constipation 10/2023 - 10/2020
2	Alopecia (Baldness) 12/2022 - 10/2020
2	Leiomyoma (Uterine Fibroids) 06/2022 - 11/2016
2	Hypertension (High Blood Pressure) 01/2022 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2022 - 05/2018
2	Rhabdomyosarcoma 01/2022 - 01/2021
2	Hypoxia (Hypoxemia) 03/2021 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 10/2019
2	Hemorrhage 01/2021 - 10/2012
2	Myocarditis (Carditis) 01/2020 - 11/2006
2	Septic Shock (Toxic Shock Syndrome) 01/2020 - 01/2017
2	Sepsis (Septicemia) 01/2020 - 01/2017
2	Leukopenia 01/2018 - 01/2017
2	Chondrosarcoma 08/2017 - 01/2012

Drug/Important Bio-Agent (IBA)

33	AnthracyclinesIBA 11/2022 - 07/2004
24	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2024 - 05/2011
15	TrabectedinIBA 03/2022 - 07/2007
13	ripretinibIBA 02/2024 - 01/2020
12	Tyrosine Kinase InhibitorsIBA 02/2024 - 01/2016
11	olaratumabIBA 03/2024 - 07/2016
10	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2008
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2006
10	AntigensIBA 01/2022 - 01/2011
10	pazopanib FDA Link 01/2022 - 01/2013
8	Imatinib Mesylate (Gleevec)FDA Link 01/2024 - 01/2013
8	Gemcitabine FDA Link 10/2023 - 01/2015
7	Phosphotransferases (Kinase)IBA 07/2022 - 02/2013
7	Ifosfamide FDA LinkGeneric 01/2018 - 05/2011
6	VaccinesIBA 11/2022 - 09/2012
6	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 03/2016
6	Monoclonal AntibodiesIBA 01/2019 - 07/2006
5	avapritinibIBA 11/2023 - 08/2020
5	eribulin FDA Link 01/2022 - 01/2017
5	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2021 - 01/2017
5	regorafenibIBA 10/2021 - 05/2015
4	Sunitinib (Sutent)FDA Link 01/2024 - 12/2022
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2023 - 09/2017
4	Docetaxel (Taxotere)FDA Link 10/2023 - 01/2015
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2019
4	Immune Checkpoint InhibitorsIBA 02/2022 - 05/2018
4	liposomal doxorubicin (Doxil)FDA Link 01/2021 - 09/2004
4	ParaffinIBA 01/2021 - 07/2008
4	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2021 - 11/2006
3	RNA (Ribonucleic Acid)IBA 03/2024 - 06/2019
3	Sirolimus (Rapamycin)FDA Link 01/2024 - 01/2014
3	Formaldehyde (Formol)FDA Link 01/2021 - 07/2008
2	Complement System Proteins (Complement)IBA 01/2023 - 01/2021
2	AntibodiesIBA 11/2022 - 01/2022
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 10/2022 - 12/2007
2	tazemetostatIBA 01/2022 - 11/2020
2	Cancer VaccinesIBA 01/2022 - 12/2018
2	selinexorIBA 01/2022 - 08/2021
2	Dihydrotachysterol (AT 10)IBA 01/2022 - 01/2012
2	CytokinesIBA 01/2022 - 01/2022
2	Neutralizing AntibodiesIBA 12/2021 - 12/2021
2	Alkylating AgentsIBA 01/2021 - 02/2015
2	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 11/2019
2	AlkaloidsIBA 01/2020 - 02/2014
2	ProdrugsIBA 05/2019 - 01/2017
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 01/2014
2	Angiogenesis InhibitorsIBA 08/2017 - 01/2013

Therapy/Procedure

73	Therapeutics 02/2024 - 11/2006
60	Drug Therapy (Chemotherapy) 05/2023 - 02/2003
16	Neoadjuvant Therapy 01/2022 - 10/2006
11	Immunotherapy 02/2022 - 01/2011
10	Radiotherapy 10/2023 - 11/2006
4	Adjuvant Chemotherapy 01/2022 - 06/2008
3	Aftercare (After-Treatment) 11/2023 - 12/2022
2	Radiofrequency Ablation 10/2023 - 05/2013
2	Metastasectomy 11/2022 - 12/2020
2	Precision Medicine 03/2021 - 01/2021
2	Combination Drug Therapy (Combination Chemotherapy) 12/2020 - 01/2010
2	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2018 - 05/2018